AngioDynamics (ANGO) PT, Estimates Cut at Piper Jaffray Following 'Tough' Qtr
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Canaccord Genuity are Buyers of AngioDynamics (ANGO) on Weakness
April 10, 2015 9:55 AM EDTCanaccord Genuity analyst Jason Mills lowered his price target on AngioDynamics (NASDAQ: ANGO) to $20.00 (from $22.00) following soft Q3 results but maintained a Buy rating. The firm would be buyers on weakness.
Mills commented, "We would be buyers on weakness associated with soft FQ3 results and downward revision to guidance. On the heels of several consecutive quarters of solid execution, including expanding top-line growth and GM, a confluence of factors negatively impacted the business in F3Q, driving revenue below expectations. A few of these challenges were out of ANGOs control (negative foreign... More
AngioDynamics (ANGO) Misses Q3 EPS by 4c, Lowers FY15 Guidance
April 9, 2015 4:04 PM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.12, $0.04 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $86.6 million versus the consensus estimate of $89.8 million.
AngioDynamics sees FY2015 EPS of $0.57-$0.60, may not compare to the consensus of $0.68. AngioDynamics sees FY2015... More
